DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Hamanishi J, Mandai M, Ikeda T. et al.
Safety and antitumor activity of anti-pd-1 antibody, nivolumab, in patients with platinum-resistant ovarian cancer.
J Clin Oncol 2015;
33: 4015-4022
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.